ArticlePatient education and counseling2009
Individuals' responses to global CHD risk: a focus group study.
Article in Patient education and counseling, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Cardiovascular risk communication strategies in primary prevention. A systematic review with narrative synthesis.Journal of advanced nursing · 2022Pooled it
- Trial
- Designing and implementing a comparative effectiveness study of two strategies for delivering high quality CHD prevention: methods and participant characteristics for the Heart to Health study.Contemporary clinical trials · 2013Trial
- A randomized trial of an intervention to improve use and adherence to effective coronary heart disease prevention strategies.BMC health services research · 2011Trial
- Effect of adding a values clarification exercise to a decision aid on heart disease prevention: a randomized trial.Medical decision making : an international journal of the Society for Medical Decision MakingTrial
- Development and usability testing of a very brief intervention for personalised cancer risk assessment to promote behaviour change in primary care using normalisation process theory.Primary health care research & development · 2020Article
- Responses to provision of personalised cancer risk information: a qualitative interview study with members of the public.BMC public health · 2017Article
- Using Predicted Cardiovascular Disease Risk in Conjunction With Blood Pressure to Guide Antihypertensive Medication Treatment.Journal of the American College of Cardiology · 2017Review
- The response to receiving phenotypic and genetic coronary heart disease risk scores and lifestyle advice - a qualitative study.BMC public health · 2016Article
- Mobile Phone-Based Lifestyle Intervention for Reducing Overall Cardiovascular Disease Risk in Guangzhou, China: A Pilot Study.International journal of environmental research and public health · 2015Article
- Risk of coronary artery disease in celiac disease population.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology AssociationArticle
- Patients' preferences for ways to communicate benefits of cardiovascular medication.Annals of family medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveTo explore how individuals respond to global coronary heart disease (CHD) risk and use it in combination with treatment information to make decisions to initiate and maintain risk reducing strategies.
methodsWe conducted four focus groups of individuals at risk for CHD (n=29), purposively sampling individuals with each of several risk factors. Two reviewers coded verbatim transcripts and arbitrated differences, using ATLAS.ti 5.2 to facilitate analysis.
resultsParticipants generally regarded the concept of global CHD risk as useful and motivating, although had questions about its precision and comprehensiveness. They identified several additional influential factors in decision-making (e.g. achievable risk, the quickness and self-evidence of results) and generally preferred lifestyle changes to medications (although most would accept medications under certain circumstances). They also noted the importance of participating in decision-making.
conclusionOur results underscore the motivating potential of global CHD risk and the importance of patient participation in decision-making. PRACTICE IMPLICATIONS: Global CHD risk is a useful adjunct to CHD prevention and can be presented in ways, and with information, that might improve CHD outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.